The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC

Show other versions (1)

THC has been used as a promising treatment approach for neurological disorders, but the highly psychoactive effects have largely warned off many scientists from pursuing it further. We conducted an intranasal treatment using low-dose THC on 12-month-old APP/PS1 mice daily for 3 months to overcome an...

Full description

Bibliographic Details
Main Authors: Brown, B. (Author), Cao, C. (Author), Chang, P. (Author), Fihurka, O. (Author), Gordon, M.N (Author), Hong, Y. (Author), Lin, X. (Author), Morgan, D. (Author), Shen, N. (Author), Wang, Y. (Author), Yan, J. (Author), Zhao, H. (Author), Zhou, Q. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
amyloid beta
APP/PS1
p-tau
THC
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items